Navigation Links
Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers

se 2 Trials

Poniard anticipates initiating the Phase 2 components of the CRC and HRPC trials in the third quarter of 2007.

The Phase 2 CRC trial will include patients newly diagnosed with metastatic disease and will evaluate the safety and efficacy of picoplatin when combined with fluorouracil and leucovorin (FOLPI) and administered biweekly compared with oxaliplatin (Eloxatin(R)) at 85 mg/m2 combined with fluorouracil and leucovorin (FOLFOX). The objective of this multi-center, double-blind, randomized Phase 2 CRC trial of approximately 140 patients is to demonstrate that picoplatin is a neuropathy-sparing platinum that has an improved side effect profile compared to oxaliplatin, enabling a larger randomized Phase 3 CRC trial that has the potential to demonstrate superior safety and efficacy compared to FOLFOX.

The objective of the Phase 2 HRPC trial is to position picoplatin as the preferred platinum in combination with docetaxel plus prednisone and improve on the efficacy of docetaxel as a single agent plus prednisone. This multi- center, open-label, single-arm trial of approximately 30 patients is designed to demonstrate superior efficacy when picoplatin is administered with docetaxel plus prednisone every three weeks in the first-line setting.

About Picoplatin

Picoplatin, the Company's lead product candidate, is designed to overcome and prevent platinum resistance associated with chemotherapy in solid tumors. In addition to the ongoing Phase 1/2 clinical trials of intravenous picoplatin in CRC and HRPC, Poniard is evaluating intravenous picoplatin in an ongoing Phase 2 clinical trial in small cell lung cancer (SCLC). On May 1, 2007, the Company announced treatment of the first patient in its pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial of intravenous picoplatin in SCLC, which is being conducted under a Special Protocol Assessment agreement with the U.S. Food and Drug Administration (FDA). Poniard re
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies

Post Your Comments:
(Date:11/6/2009)...TON, Pa., Nov. 6 In consultation w...cNeil Consumer Healthcare, Division of McNEIL-PPC,...ed number of product lots of TYLENOL® Arthrit...tive red EZ-OPEN CAP. McNeil is initiating the rec... taste associated with these lots that led to a sm...
(Date:11/6/2009)... Repossessions and liquidations of... quarter of 2009 declined as compared to similar f...ment,s NasTrac Quarterly Index (NQI). The figures...oth repossessions and orderly liquidations, also i...tion and printing equipment, offering mixed news o...
(Date:11/6/2009)...6 Derma Sciences, Inc....ced wound care products, announced plans to releas...Monday, November 16, 2009. The Company will hold a...lts at 11:00 am EST. Interested parties should cal...ernational), with passcode 81416481 to access the ...
Breaking Medicine Technology:McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2New research discovers link between smoking and brain damage 49757 1New research discovers link between smoking and brain damage 49757 2NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 1NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 2NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 3NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 4NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 5Saint Vincent Health Center Ensures Regulatory Compliance with SIS 49754 1Saint Vincent Health Center Ensures Regulatory Compliance with SIS 49754 2Saint Vincent Health Center Ensures Regulatory Compliance with SIS 49754 3
...inger, MD, PhD ,Contributing Editor ,Harvard M...Aspergillus represent two of the most important c...n virtually every environment, and hospitals are n...s of vaginitis ( Candida ) and pulmonary hypersens...m these localized conditions, but by virtue of int...
... M.D. Contributing Editor Clinical guidelines from...emergency medicine have all emphasized the importa... acute myocardial infarction. The measurement of ...e fraction of patients presenting with acute coron... About 30% of patients previously considered to h...
Other Medicine Technology:New Assays to Detect Disseminated Fungal Infections 2New Assays to Detect Disseminated Fungal Infections 3Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 2Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 3
(Date:11/8/2009)... , AARP Praises House Passage of Health Care...rengthen Medicare, improve coverage for all Americ...SNewswire/ -- ,, SUMMARY: Last night the Uni...l health care reform legislation that would streng...y insurance companies that prices millions of Amer...
(Date:11/8/2009)... , Higher Costs and Crushing Taxes Nail Natio...ire-USNewswire/ -- In response to U.S. House passa...ness & Entrepreneurship Council (SBE Council) ...owing statement: ,, "Make no mistake, those vo...b creators with higher costs and crushing taxes an...
(Date:11/8/2009)... , 3D Global Solutions is...n program managing the proposal effort for ReSound...n VA Digital Hearing Aid contract. The award inclu... the Department of Defense and other federal agenc...B) November 8, 2009 -- 3D Global Solutions is plea...
(Date:11/8/2009)... , WASHINGTON, Nov. 7 /PRNewswire-USNewswire/... Stupak, Pitts, Kaptur, Dahlkemper, Smith, Ellswor...h Care for America Act" (H.R. 3962). The amendment...l funding for abortion and for benefits packages t...s, both those who receive affordability credits an...
(Date:11/8/2009)... , WASHINGTON, Nov. 8 /PRNewswire-USNewswire/...merica (PhRMA) Senior Vice President Ken Johnson r...e health care reform bill: ,, "We are disappoin...iness echoed by millions of hardworking Americans ...House of Representatives who voted against the bil...
Breaking Medicine News(10 mins):Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3
...ot like it much! According to a new study, those l...an increased risk of suffering a heart attack. ...s of urban middle-aged adults, living on high-tr... if work environment reverberated with high noise ...
...e schools of England in a move to slash the rising...e currently 2,409 nurses who work in primary and s... announcement signals a massive extension, reporte... each small group of state primary schools and the...
...hat it will be creating a new 'breast cancer dicti...ly// develops between a doctor and a patient due t...minology by the latter. This announcement was made...s possible about their disease, but are unable to ...
...zard today with a magnitude of about one in every ... defibrillators (IAD) have now come to our rescue/...harge from these apparatus have brought many back ...ho were leading normal lives, with the first sign ...
... accused of subjecting patients to unwarranted fer... grave professional misdemeanor by the General Med... London fertility Center, has always been consiste...Professor Craft has executed pioneering work in hi...
... System say the federal government could promote f...manner that would ultimately save lives. They sugg... Flu vaccination programme, //by direct advertisin... due to influenza virus. They want the government ...
Other Medicine News:Health News:Seconds Between Life And Death 2Health News:Influenza Vaccination For The Elderly 2
Gc-globulin (actin-free) ELISA Kit
...Mark The X & Y Coordinates At The 6 & 9 Oclock Pos...ameter & 13mm Outer Diameter Radial Axis Marks Cov...iated With Hand-Held Markers By Mounting The Devic...ng To Ensure A More Perfect Mark. , ,Etched C...
180.XENON
... diagnostic tool in determining functionality of a...hen deciding courses of treatment for patients rec...tment, recurring infections and autoimmune dieseas... autoimmune diseases giving rise to high titers of...
Medicine Products: